PAR1 Is a Matrix Metalloprotease-1 Receptor that Promotes Invasion and Tumorigenesis of Breast Cancer Cells

This publication has 40 references indexed in Scilit:

• Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage
  Biochemical Journal, 2003
• Structural Basis for Thrombin Activation of a Protease-Activated Receptor
  Chemistry & Biology, 2003
• A third‐generation matrix metalloproteinase (MMP) inhibitor (ONO‐4817) combined with docetaxel suppresses progression of lung micrometastasis of MMP‐expressing tumor cells in nude mice
  International Journal of Cancer, 2002
• Stabilization of atherosclerotic plaques: New mechanisms and clinical targets
  Nature Medicine, 2002
• New functions for the matrix metalloproteinases in cancer progression
  Nature Reviews Cancer, 2002
• Gene expression profiling predicts clinical outcome of breast cancer
  Nature, 2002
• A Role for Thrombin Receptor Signaling in Endothelial Cells During Embryonic Development
  Science, 2001
• Systematic variation in gene expression patterns in human cancer cell lines
  Nature Genetics, 2000
• Inhibition of Matrix Metalloproteinases by Peptidyl Hydroxamic Acids
  Biochemical and Biophysical Research Communications, 1994
• Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation
  Cell, 1991